Previous close | 0.0200 |
Open | 0.0210 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0210 - 0.0210 |
52-week range | 0.0113 - 0.0499 |
Volume | |
Avg. volume | 29,565 |
Market cap | 12.526M |
Beta (5Y monthly) | 0.28 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0200 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCQB: ALRTF), a diabetes management company, announces the patent application titled Method and System of Monitoring a Diabetes Treatment Plan ("Predictive A1c") has been granted in Singapore and has received notice of allowance in the United States.
SINGAPORE, Aug. 07, 2023 (GLOBE NEWSWIRE) -- ALR Technologies SG Ltd. (“ALRT” or the “Company”) (OTCQB:ALRTF), the diabetes management company, announces plans to launch the GluCurve Pet CGM (“GluCurve”) in Canada during Q3 2023 with a direct to veterinarian clinic sales model through GluCurve.ca. The Canadian website will go live on or before August 28th when the Company expects to begin taking orders. The inventory from the purchase order announced on June 1, 2023 will now be used for the Cana
SINGAPORE, June 01, 2023 (GLOBE NEWSWIRE) -- ALR Technologies SG Ltd. (“ALRT”) (OTCQB:ALRTF), the diabetes management company, announces the issuance of a purchase order for the first shipment of second generation CGM hardware used in the GluCurve Pet CGM. The shipment is expected to be delivered to ALRT’s distributor in early Q3 with a sales value of USD $350,000. “We quickly sold out of inventory during our soft launch in January due to tremendous interest in the GluCurve Pet CGM from veterina